TNF Inhibitors Linked to Increased Multiple Sclerosis Risk
In a large, retrospective cohort study, investigators found a slightly increased risk for MS in patients on TNF therapy, especially among those being treated for rheumatic disease.
Medscape Medical News
source https://www.medscape.com/viewarticle/983767?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/983767?src=rss
Comments
Post a Comment